Llwytho...
ABHD6: its place in endocannabinoid signaling and beyond.
The endocannabinoid (eCB) signaling system modulates neurotransmission and inflammation, amongst other physiological functions. Its newest member, α/β-hydrolase domain containing 6 (ABHD6), has emerged as a promising therapeutic target to treat several devastating diseases, including epilepsy. We re...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Trends Pharmacol Sci |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6445269/ https://ncbi.nlm.nih.gov/pubmed/30853109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2019.02.002 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|